[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2091237T3 - Nuevo procedimiento para la produccion de proteina no fusionada en e. coli. - Google Patents

Nuevo procedimiento para la produccion de proteina no fusionada en e. coli.

Info

Publication number
ES2091237T3
ES2091237T3 ES90810890T ES90810890T ES2091237T3 ES 2091237 T3 ES2091237 T3 ES 2091237T3 ES 90810890 T ES90810890 T ES 90810890T ES 90810890 T ES90810890 T ES 90810890T ES 2091237 T3 ES2091237 T3 ES 2091237T3
Authority
ES
Spain
Prior art keywords
rigf
unmelted
coli
protein
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90810890T
Other languages
English (en)
Inventor
Albert Dr Schmitz
Walter Dr Marki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2091237T3 publication Critical patent/ES2091237T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/73—Expression systems using phage (lambda) regulatory sequences
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UN PROCESO PARA LA PREPARACION DE UN RECOMBINANTE "IGF-II"(RLGF-II) SIN UNA PORCION DE PROTEINA EXTRAÑA ASOCIADA DE MANERA COVALENTE Y SIN UNA METIONINA ASOCIADA AL TERMINAL-N O UN DERIVADO DE METIONINA O DE UNA SAL DE DICHO "IGF-II", "RLGF-II" PRODUCIDO POR DICHO METODO, VECTORES HIBRIDOS QUE CONTIENEN "ADN" CODIFICANDO DICHO "RLGF-II", LOS RECEPTORES TRANSFORMADOS POR DICHOS VECTORES, Y UN PROCESO PARA EL AISLAMIENTO DE DICHO "RIGF-II" DESDE LA CELULA RECEPTORA Y PASA EN UNA FORMA ACTIVA BIOLOGICAMENTE.
ES90810890T 1989-11-29 1990-11-20 Nuevo procedimiento para la produccion de proteina no fusionada en e. coli. Expired - Lifetime ES2091237T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898927008A GB8927008D0 (en) 1989-11-29 1989-11-29 Novel process for the production of unfused protein in e.coli

Publications (1)

Publication Number Publication Date
ES2091237T3 true ES2091237T3 (es) 1996-11-01

Family

ID=10667136

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90810890T Expired - Lifetime ES2091237T3 (es) 1989-11-29 1990-11-20 Nuevo procedimiento para la produccion de proteina no fusionada en e. coli.

Country Status (12)

Country Link
US (2) US5210028A (es)
EP (1) EP0434605B1 (es)
JP (2) JPH03228682A (es)
AT (1) ATE142694T1 (es)
CA (1) CA2030947A1 (es)
DE (1) DE69028499T2 (es)
DK (1) DK0434605T3 (es)
ES (1) ES2091237T3 (es)
GB (1) GB8927008D0 (es)
GR (1) GR3020993T3 (es)
IE (1) IE74173B1 (es)
PT (1) PT96004B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3486216T2 (de) * 1983-04-25 1994-02-17 Chiron Corp Hybrid-DNS-Synthesis von reifen insulinähnlichen Wachstumsfaktoren.
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
US5532142A (en) * 1993-02-12 1996-07-02 Board Of Regents, The University Of Texas System Method of isolation and purification of fusion polypeptides
US5407810A (en) * 1993-08-20 1995-04-18 Genentech, Inc. Aqueous multiple-phase isolation of polypeptide
KR100309700B1 (ko) * 1994-01-15 2001-12-15 성재갑 재조합단백질의활성상태로의재구성방법
AU3545795A (en) * 1994-09-08 1996-03-27 Chiron Corporation A method of improved production of insulin-like growth factor
US6489450B2 (en) * 1998-07-09 2002-12-03 University Technology Corporation High pressure refolding of protein aggregates and inclusion bodies
US6121421A (en) * 1998-08-21 2000-09-19 Abbott Laboratories Methods for isolating recombinant β-casein
MXPA03003867A (es) * 2000-10-31 2004-10-15 Univ Colorado Regents Desagregacion mejorada de proteina y replegamiento utilizando alta presion.
US7105327B1 (en) * 2001-06-15 2006-09-12 Bharat Biotech International, Ltd. Recombinant streptokinase
DK1472286T3 (da) * 2002-02-05 2007-08-20 Geymonat Spa Produktionsmetode til rekombinant placental vækstfaktor
AU2003236038A1 (en) * 2002-04-10 2003-10-20 Ajinomoto Co., Inc. Recombinant dna having hydantoinase gene and carbamylase gene and process for producing amino acid
US6969769B2 (en) * 2002-06-14 2005-11-29 Vanson Halosource, Inc. N-halamine siloxanes for use in biocidal coatings and materials
US20080161242A1 (en) * 2006-09-15 2008-07-03 Randolph Theodore W High pressure treatment of proteins for reduced immunogenicity
CA2779688C (en) * 2009-11-05 2020-01-14 Quest Diagnostics Investments Incorporated Quantitation of insulin-like growth factor-i and insulin-like growth factor-ii with high-resolution mass spectrometry
CN104911203A (zh) * 2015-06-30 2015-09-16 成都易胜科生物科技有限公司 一种重组人胰岛素的工业制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2586170A (en) * 1946-10-04 1952-02-19 Peerless Tool & Engineering Co Fishing tackle assembly
US2807905A (en) * 1955-11-07 1957-10-01 Jesse E Ford Fishing lure and plug retriever
US2809460A (en) * 1956-03-23 1957-10-15 Belty L Taylor Fishing lure retriever
US2807906A (en) * 1956-08-06 1957-10-01 Mun Henry Chan Fishing tackle retriever
US3144728A (en) * 1962-02-19 1964-08-18 Stevens Marvin Lure retriever
US3156064A (en) * 1963-08-21 1964-11-10 Herbert J Czirr Means to recover a lure or the like
US4408411A (en) * 1981-05-21 1983-10-11 Skarnells David B Fishing lure retriever
US4620948A (en) * 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4536984A (en) * 1983-02-18 1985-08-27 Leon Kowal Retrieval device for fishing tackle
DE3486216T2 (de) * 1983-04-25 1994-02-17 Chiron Corp Hybrid-DNS-Synthesis von reifen insulinähnlichen Wachstumsfaktoren.
WO1985000831A1 (en) * 1983-08-10 1985-02-28 Amgen Microbial expression of insulin-like growth factor
US4758512A (en) * 1984-03-06 1988-07-19 President And Fellows Of Harvard College Hosts and methods for producing recombinant products in high yields
EP0189481B1 (en) * 1984-07-13 1991-01-23 Chiron Corporation Insulin-like growth factor ii
US4738921A (en) * 1984-09-27 1988-04-19 Eli Lilly And Company Derivative of the tryptophan operon for expression of fused gene products
EP0193112A3 (en) * 1985-02-22 1987-02-25 The Trustees Of Columbia University In The City Of New York Cdna encoding mammalian insulin-like growth factor ii
SE8505922D0 (sv) * 1985-12-13 1985-12-13 Kabigen Ab Construction of an igg binding protein to facilitate downstream processing using protein engineering
US4885163A (en) * 1987-02-24 1989-12-05 Eli Lilly And Company Topical use of IGF-II for wound healing
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
EP0289314B1 (en) * 1987-04-28 1994-10-12 Roche Diagnostics GmbH Use of IGF-II in the treatment of bone disorders
US4961969A (en) * 1987-05-11 1990-10-09 Cetus Corporation Process for recovering microbially produced interferon-β
GB8723660D0 (en) * 1987-10-08 1987-11-11 British Bio Technology Synthetic gene

Also Published As

Publication number Publication date
GR3020993T3 (en) 1996-12-31
PT96004B (pt) 1998-01-30
ATE142694T1 (de) 1996-09-15
US5708148A (en) 1998-01-13
PT96004A (pt) 1991-09-13
CA2030947A1 (en) 1991-05-30
US5210028A (en) 1993-05-11
GB8927008D0 (en) 1990-01-17
EP0434605B1 (en) 1996-09-11
EP0434605A2 (en) 1991-06-26
IE74173B1 (en) 1997-07-02
JP2001008697A (ja) 2001-01-16
DE69028499T2 (de) 1997-03-13
DK0434605T3 (da) 1996-09-30
DE69028499D1 (de) 1996-10-17
JPH03228682A (ja) 1991-10-09
IE904294A1 (en) 1991-06-05
EP0434605A3 (en) 1991-11-06

Similar Documents

Publication Publication Date Title
ES2091237T3 (es) Nuevo procedimiento para la produccion de proteina no fusionada en e. coli.
DE68929402D1 (de) Verfahren zur herstellung von wasserlöslichen polypeptiden
PT866876E (pt) Processo para a preparacao de proteinas recombinantes em e. coli por fermentacao a elevada densidade celular
DE69019609D1 (de) Proteine und deren Herstellung.
DE69412593D1 (de) Anthrax-toxin-fusionsproteine und deren verwendungen
PT850310E (pt) Molecula de dna circular com origem de replicacao condicional, metodo para a sua preparacao e utilizacao da mesma na terapia genica
ES2072893T3 (es) Endoproteasa kex2 y procedimiento para su produccion.
ES524816A0 (es) Procedimiento para la produccion de polipetidos mediante levadura.
DE60033293D1 (de) Neue b7-4 moleküle und deren verwendungen
PT955313E (pt) Nova proteina e processo para a sua producao
ATE68826T1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
ATE263836T1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
RU93045577A (ru) Слитные полипептиды
NO862690D0 (no) Monoklonale antistoffer og antigener for humane ikke-liten-celle lungekarcinomer (nsclc).
KR930013115A (ko) Dna 분자 및 숙주
AU2795989A (en) Production of gonorrheal pi proteins and vaccines
WO1994003601A3 (en) Cloning, expression and uses for neurocan as a chondroitin sulfate proteoglycan
YU69691A (sh) Postupak za pripremu stranih proteina u streptomicetama
ES2136062T3 (es) Plasmido pctd aislado de chlamydia trachomatis serotipo d, genes y proteinas codificados por el mismo; plasmidos recombinantes para la expresion de dichos genes en sistemas heterologos como proteinas recombinantes de fusion, preparacion de dichas proteinas recombinantes y ...
ATE382089T1 (de) Verfahren zum herstellen eines rekombinanten proteins
AU1321988A (en) The cloning of malaria-specific dna sequences: isolation of the gene for the 140 kd protein
WO2001029197A3 (en) Novel germinal center kinase cell cycle proteins, compositions and methods of use
TH43244A (th) การสร้างพอลิเพพไทด์ไม่ชอบน้ำโดยแบคทีเรีย
FI934079A (fi) Menetelmä fuusioproteiinin valmistamiseksi
WO2001029072A3 (en) P15paf cell cycle proteins associated with pcna, compositions and methods of use

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 434605

Country of ref document: ES